Spitalul Clinic De Psihiatrie Si Neurologie Brasov
- Address
- lock Available on a paid plan
Spitalul Clinic De Psihiatrie Si Neurologie Brasov - Psychiatric and Neurological Research Center
Spitalul Clinic De Psihiatrie Si Neurologie Brasov is a specialized clinical research facility focused on advancing treatments for complex psychiatric and neurological disorders. The center demonstrates comprehensive expertise in conducting phase trials across a diverse spectrum of mental health conditions and neurodegenerative diseases, positioning itself as a key contributor to innovative therapeutic development in Central Europe.
- Major Depressive Disorder treatment including adjunctive therapies for treatment-resistant depression and depression with insomnia symptoms
- Schizophrenia research examining novel antipsychotic treatments and symptom management strategies
- Alzheimer's Disease and dementia studies focusing on behavioral symptoms including agitation management
- Multiple Sclerosis clinical trials evaluating disease-modifying therapies for relapsing forms
The facility's research portfolio reflects a strong emphasis on neuropsychiatric disorders and neurodegenerative conditions, with particular expertise in evaluating both efficacy and long-term safety profiles of emerging pharmacological agents. The center's involvement in multiple comparative effectiveness studies and open-label extension trials demonstrates their capability to support both early-phase and advanced clinical research programs, contributing valuable real-world evidence for adjunctive treatment strategies and patient populations with inadequate response to standard therapies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 therapeutic areas and 15 of 19 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Spitalul Clinic De Psihiatrie Si Neurologie Brasov
lock Showing 1 of 17 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Global, Phase 3, Multicenter, Open-Label Study to Assess the Long-Term Safety and Tolerability of NBI-1117568 in Adults with Schizophrenia | Neurocrine Biosciences Inc. | Phase III | Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 19 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Trospium Chloride | 5 | Unknown | 2025-09-25 | 2026-06-01 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.